Cargando…
P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES
| Autores principales: | , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430928/ http://dx.doi.org/10.1097/01.HS9.0000970572.74541.06 |
| _version_ | 1785091077248647168 |
|---|---|
| author | Mateos, Maria-Victoria Engelhardt, Monika Leleu, Xavier Gironella Mesa, Mercedes Auner, Holger W. Cavo, Michele Dimopoulos, Meletios A. Bianco, Martina Marino Merlo, Giovanni la Porte, Charles Moreau, Philippe |
| author_facet | Mateos, Maria-Victoria Engelhardt, Monika Leleu, Xavier Gironella Mesa, Mercedes Auner, Holger W. Cavo, Michele Dimopoulos, Meletios A. Bianco, Martina Marino Merlo, Giovanni la Porte, Charles Moreau, Philippe |
| author_sort | Mateos, Maria-Victoria |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10430928 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104309282023-08-17 P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES Mateos, Maria-Victoria Engelhardt, Monika Leleu, Xavier Gironella Mesa, Mercedes Auner, Holger W. Cavo, Michele Dimopoulos, Meletios A. Bianco, Martina Marino Merlo, Giovanni la Porte, Charles Moreau, Philippe Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10430928/ http://dx.doi.org/10.1097/01.HS9.0000970572.74541.06 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Mateos, Maria-Victoria Engelhardt, Monika Leleu, Xavier Gironella Mesa, Mercedes Auner, Holger W. Cavo, Michele Dimopoulos, Meletios A. Bianco, Martina Marino Merlo, Giovanni la Porte, Charles Moreau, Philippe P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES |
| title | P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES |
| title_full | P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES |
| title_fullStr | P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES |
| title_full_unstemmed | P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES |
| title_short | P917: SELINEXOR, BORTEZOMIB, AND DEXAMETHASONE IN PATIENTS WITH PREVIOUSLY TREATED MULTIPLE MYELOMA: UPDATED RESULTS OF BOSTON TRIAL BY PRIOR THERAPIES |
| title_sort | p917: selinexor, bortezomib, and dexamethasone in patients with previously treated multiple myeloma: updated results of boston trial by prior therapies |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430928/ http://dx.doi.org/10.1097/01.HS9.0000970572.74541.06 |
| work_keys_str_mv | AT mateosmariavictoria p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT engelhardtmonika p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT leleuxavier p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT gironellamesamercedes p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT aunerholgerw p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT cavomichele p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT dimopoulosmeletiosa p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT biancomartina p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT marinomerlogiovanni p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT laportecharles p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies AT moreauphilippe p917selinexorbortezomibanddexamethasoneinpatientswithpreviouslytreatedmultiplemyelomaupdatedresultsofbostontrialbypriortherapies |